Single-fraction stereotactic boost in high-risk early breast cancer: safety and early toxicity results of a phase II trial

Clinical and Translational Radiation Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles